Cited by 502Sepsis Diagnosis and TreatmentAntibiotics Pharmacokinetics and EfficacyAcute Kidney Injury Research

The DOI matches its Crossref record; 23 of the 25 references it cites were found in a registry or an index.

Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial

Open access

Dellinger, R. Phillip, Bagshaw, Sean M., Antonelli, Massimo, Foster, Debra M., Klein, David J., Marshall, John C., Palevsky, Paul M., Weisberg, Lawrence S., Schorr, Christa A., Trzeciak, Stephen, Walker, Paul M., for the EUPHRATES Trial Investigators·2018·JAMA

DOI 10.1001/jama.2018.14618PMC PMC6233793

Open this paper in CoChat — free account Open PDF

Abstract

Importance: Polymyxin B hemoperfusion reduces blood endotoxin levels in sepsis. Endotoxin activity can be measured in blood with a rapid assay. Treating patients with septic shock and elevated endotoxin activity using polymyxin B hemoperfusion may improve clinical outcomes. Objective: To test whether adding polymyxin B hemoperfusion to conventional medical therapy improves survival compared with conventional therapy alone among patients with septic shock and high endotoxin activity. Design, Setting, and Participants: Multicenter, randomized clinical trial involving 450 adult critically ill patients with septic shock and an endotoxin activity assay level of 0.60 or higher enrolled between September 2010 and June 2016 at 55 tertiary hospitals in North America. Last follow-up was June 2017. Interventions: Two polymyxin B hemoperfusion treatments (90-120 minutes) plus standard therapy completed within 24 hours of enrollment (n = 224 patients) or sham hemoperfusion plus standard therapy (n = 226 patients). Main Outcomes and Measures: The primary outcome was mortality at 28 days among all patients randomized (all participants) and among patients randomized with a multiple organ dysfunction score (MODS) of more than 9. Results: Among 450 eligible enrolled patients (mean age, 59.8 years; 177 [39.3%] women; mean APACHE II score 29.4 [range, 0-71 with higher scores indicating greater severity), 449 (99.8%) completed the study. Polymyxin B hemoperfusion was not associated with a significant difference in mortality at 28 days among all participants (treatment group, 84 of 223 [37.7%] vs sham group 78 of 226 [34.5%]; risk difference [RD], 3.2%; 95% CI, -5.7% to 12.0%; relative risk [RR], 1.09; 95% CI, 0.85-1.39; P = .49) or in the population with a MODS of more than 9 (treatment group, 65 of 146 [44.5%] vs sham, 65 of 148 [43.9%]; RD, 0.6%; 95% CI, -10.8% to 11.9%; RR, 1.01; 95% CI, 0.78-1.31; P = .92). Overall, 264 serious adverse events were reported (65.1% treatment group vs 57.3% sham group). The most frequent serious adverse events were worsening of sepsis (10.8% treatment group vs 9.1% sham group) and worsening of septic shock (6.6% treatment group vs 7.7% sham group). Conclusions and Relevance: Among patients with septic shock and high endotoxin activity, polymyxin B hemoperfusion treatment plus conventional medical therapy compared with sham treatment plus conventional medical therapy did not reduce mortality at 28 days. Trial Registration: ClinicalTrials.gov Identifier: NCT01046669.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2018.14618

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Self-citation
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Self-citation
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,869
Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock
Cruz, D. N., Antonelli, M. M., Fumagalli, R., Foltran, F., Brienza, N., Donati, A., Malcangi, V., Petrini, F., Volta, G., Pallavicini, F. M. B., et al. (2009) · JAMA · doi:10.1001/jama.2009.856 · Cited by 841
Self-citation
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis: The ACCESS Randomized Trial
Opal, S. M., Laterre, P.-F., Francois, B., LaRosa, S. P., Angus, D. C., Mira, J.-P., Wittebole, X., Dugernier, T., Perrotin, D., Tidswell, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.2194 · Cited by 812
Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock
Opal, S. M., Scannon, P. J., Vincent, J., White, M., Carroll, S. F., Palardy, J. E., Parejo, N. A., Pribble, J. P., & Lemke, J. H. (1999) · The Journal of Infectious Diseases · doi:10.1086/315093 · Cited by 609
Surviving Sepsis Campaign
Levy, M. M., Rhodes, A., Phillips, G. S., Townsend, S. R., Schorr, C., Beale, R. J., Osborn, T. M., Lemeshow, S. A., Chiche, J., Artigas, A., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000723 · Cited by 583
Self-citation
Treatment of Septic Shock with Human Monoclonal Antibody HA-1A
McCloskey, R. V., Straube, R. C., Sanders, C., Smith, S. M., Smith, C. R., & and CHESS Trial Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-1-199407010-00001 · Cited by 492
Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial
The ABDOMIX Group, Payen, D. M., Guilhot, J., Launey, Y., Lukaszewicz, A. C., Kaaki, M., Veber, B., Pottecher, J., Joannès-Boyau, O., Martin‐Lefèvre, L., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3751-z · Cited by 418
Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial
Levin, M., Quint, P. A., Goldstein, B., Barton, P., Bradley, J. S., Shemie, S., Yeh, T. S., Kim, S. S., Cafaro, D. P., Scannon, P. J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02712-4 · Cited by 408

Show all 25 references

Sorted by citations

Items 401–500 of 501

Improving Survival in Sepsis: Optimizing Treatment Duration with Polymyxin-B Immobilized Hemoperfusion—A Comprehensive Network Meta-AnalysisPreprint
Zhao, Y., Gao, W., He, R., Zhou, J., Fu, R., Sun, Z., Li, J.-K., Liu, H.-Y., Gong, H., Zhang, B., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4367644/v1
Sepsis-Associated Acute Kidney Injury
Saraiva, I. E. B., Zaidi, S. A., Prenna, S., Marengo, M., Piscia, R., Colombatto, A., Cantaluppi, V., & Gómez, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00088-7
Nierenersatztherapie in der Intensivmedizin
Enghard, P., Krüger, A., & Jörres, A. (2024) · Nephrologie aktuell · doi:10.1055/a-2254-7940
Pathophysiology of Sepsis: A Potential Pathway for Defining Distinct Clinical Phenotypes and Potential Targeted Therapies Including Therapeutic Plasma Exchange
Keith, P. D., Conrad, T. S., Eaton, J., & Scott, L. K. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006157
Innovationen in der Intensivpflege-Nephrologie
Kusirisin, P., Kaewdoungtien, P., Thanapongsatorn, P., Peerapornratana, S., & Srisawat, N. (2024) · Springer eBooks · doi:10.1007/978-3-031-65236-3_21
Analysis of Trends and Influencing Factors of Cytokine-Adsorbing Therapies: A Nationwide Ecological Study in Japan
Ono, S., & Shimizu, K. (2024) · Cureus · doi:10.7759/cureus.73489
Extracorporeal Blood Purification for Immunomodulatory or Hybrid Support in Sepsis
Rosa, S. D., Villa, G., Ferrari, F., Pace, R., & Ferrer, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-66541-7_46
The endotoxin activity assay as a useful guide for the application of polymyxin B hemoperfusion: a case report
Song, H., & Park, S. J. (2024) · Archives of Pediatric Critical Care · doi:10.32990/apcc.2024.00122
Categories, Characteristics, and Applications of Adsorbents for Blood Purification
Ren, J., Huang, C., Yao, G., & Ji, F. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165412-00181
Effects of polymyxin B haemoperfusion on septic shock caused by Gram-positive bacteria
Tanaka, S., Haruna, J., Kazuma, S., Tatsumi, H., & Masuda, Y. (2025) · Anaesthesia and Intensive Care · doi:10.1177/0310057x241284300
Extracorporeal therapies for post-liver transplant recipient: The road less traveled
Pachisia, A. V., Govil, D., Jagadeesh, K. N., Patel, S. J., Harne, R., Pal, D., Tyagi, P., Pattajoshi, S., Brar, K., Patel, P., et al. (2025) · World Journal of Transplantation · doi:10.5500/wjt.v15.i3.101975
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024 (J-SSCG2024) Summary
Kuwana, T. (2025) · Journal of Nihon University Medical Association · doi:10.4264/numa.84.4_127
Extrakorporale Therapie bei Sepsis – wann steht das therapeutische Fenster offen?
Fassbender, C., & Klingel, R. (2025) · Nephrologie aktuell · doi:10.1055/a-2551-7304
Group A streptococcal primary peritonitis and toxic shock syndrome
Yamamoto, A., Takagi, R., Yamamoto, M., Yokoyama, H., Morimoto, Y., Yokoe, T., Ojima, E., Uchida, K., & Mohri, Y. (2025) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-025-02225-9
Biomarkers for Predicting the Use of Selective Hemosorption of Lipopolysaccharides in Sepsis and Septic Shock
Rey, S. I., Анатольевич, Б. Г., Боровкова, Н. В., Godkov, M. A., Klychnikova, E. V., Кузнецова, Т. Е., Maksimov, A. A., & Александрович, Т. И. (2025) · Russian Sklifosovsky Journal Emergency Medical Care · doi:10.23934/2223-9022-2025-14-3-499-510
Differential Impact of Polymyxin B Hemadsorption on Long‐Term Mortality in Septic Shock: A Retrospective Analysis of Intra‐Abdominal Versus Extra‐Abdominal Infections
Tanaka, T., Fujino, K., Tsujita, Y., Matsumoto, Y., Fujino, M., Miyatake, H., Mizumura, N., Shimizu, J., Kishimoto, T., & Shiomi, N. (2025) · Artificial Organs · doi:10.1111/aor.70023
Clinical experience with PMX cartridge in sepsis and septic shock management
Lassola, S., Rosa, S. D., & Ronco, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33074-2.00015-9
Endotoxin pathophysiology
Koolen, J. J., Snoek, B., Waalders, N. J. B., & Pickkers, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33074-2.00002-0
Endotoxin in trauma
Charbonney, E., & Marshall, J. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33074-2.00012-3
Self-citation
Endotoxin and the gut microbiome
Harris, B. R. E., Barwatt, J., Gajic, O., & Karnatovskaia, L. V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33074-2.00008-1
Therapeutic rationale for endotoxin removal with polymyxin B immobilized fiber column hemoperfusion (PMX-HP) for endotoxemic septic shock
Klein, D. J., & Shoji, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33074-2.00007-x
Self-citation
Endotoxic septic shock
Kamaluddin, E., & Foster, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33074-2.00011-1
Self-citation
Endotoxin signaling: the TLR4 pathway and alternates
Gómez, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33074-2.00010-x
Antiendotoxin therapies
Kellum, J. A., Legrand, M. M., & Walker, P. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33074-2.00006-8
Self-citation
Additional file 1 of Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study
Fujimori, K., Tarasawa, K., & Fushimi, K. (2021) · Figshare · doi:10.6084/m9.figshare.16683065
Additional file 2 of Effects of enhanced adsorption haemofiltration versus haemoadsorption in severe, refractory septic shock with high levels of endotoxemia: the ENDoX bicentric, randomized, controlled trial
Wendel‐Garcia, P. D., Eberle, B. M., Kleinert, E.-M., Hilty, M. P., Blumenthal, S., Spanaus, K., Fodor, P., & Maggiorini, M. (2024) · Figshare · doi:10.6084/m9.figshare.24820016
Additional file 1 of Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
Goossens, C., Weckx, R., Derde, S., Perre, S. V., Derese, I., Van Veldhoven, P. P., Ghesquière, B., Van den Berghe, G., & Langouche, L. (2021) · Figshare · doi:10.6084/m9.figshare.15000102
Additional file 6 of Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
Awano, N., Jo, T., Izumo, T., Inomata, M., Ito, Y., Morita, K., Matsui, H., Fushimi, K., Urushiyama, H., Nagase, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26625820
Additional file 1 of Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
Awano, N., Jo, T., Izumo, T., Inomata, M., Ito, Y., Morita, K., Matsui, H., Fushimi, K., Urushiyama, H., Nagase, T., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24295593
Additional file 3 of Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
Awano, N., Jo, T., Izumo, T., Inomata, M., Ito, Y., Morita, K., Matsui, H., Fushimi, K., Urushiyama, H., Nagase, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26625811
Additional file 8 of Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
Awano, N., Jo, T., Izumo, T., Inomata, M., Ito, Y., Morita, K., Matsui, H., Fushimi, K., Urushiyama, H., Nagase, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26625826
Additional file 9 of Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
Awano, N., Jo, T., Izumo, T., Inomata, M., Ito, Y., Morita, K., Matsui, H., Fushimi, K., Urushiyama, H., Nagase, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26625829
Additional file 1 of Peritoneal sepsis caused by Escherichia coli triggers brainstem inflammation and alters the function of sympatho-respiratory control circuits
Kola, G., Clifford, C., Campanaro, C. K., Dhingra, R. R., Dutschmann, M., Jacono, F. J., & Dick, T. E. (2024) · Figshare · doi:10.6084/m9.figshare.25194795
Additional file 1 of Targeted therapy using polymyxin B hemadsorption in patients with sepsis: a post-hoc analysis of the JSEPTIC-DIC study and the EUPHRATES trial
Osawa, I., Goto, T., Kudo, D., Hayakawa, M., Yamakawa, K., Kushimoto, S., Foster, D., Kellum, J. A., & Doi, K. (2023) · Figshare · doi:10.6084/m9.figshare.23557874
Self-citation
Additional file 2 of Beneficial effects of recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project
Stasi, A., Fiorentino, M., Franzin, R., Staffieri, F., Carparelli, S., Losapio, R., Crovace, A., Lacitignola, L., Cimmarusti, M. T., Murgolo, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24484174
Additional file 7 of Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
Awano, N., Jo, T., Izumo, T., Inomata, M., Ito, Y., Morita, K., Matsui, H., Fushimi, K., Urushiyama, H., Nagase, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26625823
Additional file 10 of Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
Awano, N., Jo, T., Izumo, T., Inomata, M., Ito, Y., Morita, K., Matsui, H., Fushimi, K., Urushiyama, H., Nagase, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26625832
Additional file 1 of Bayesian methods: a potential path forward for sepsis trials
Tomlinson, G., Al-Khafaji, A. H., Conrad, S. A., Factora, F. N., Foster, D., Galphin, C. M., Gunnerson, K. J., Khan, S., Kohli-Seth, R. D., McCarthy, P. J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24532001
Self-citation
Additional file 5 of Association of immediate reinsertion of new catheters with subsequent mortality among patients with suspected catheter infection: a cohort study
Zhong, Y., Deng, L., Zhou, L., Liao, S., Yue, L., Wen, S. W., Xie, R., Lu, Y., Zhang, L., Tang, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19728352
Additional file 1 of Towards personalized medicine: a scoping review of immunotherapy in sepsis
Slim, M. A., van Mourik, N., Bakkerus, L., Fuller, K., Acharya, L. S., Giannidis, T., Dionne, J. C., Oczkowski, S. J. W., Netea, M. G., Pickkers, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26726717
Additional file 1 of Beneficial effects of recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project
Stasi, A., Fiorentino, M., Franzin, R., Staffieri, F., Carparelli, S., Losapio, R., Crovace, A., Lacitignola, L., Cimmarusti, M. T., Murgolo, F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24483559
Additional file 2 of Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
Awano, N., Jo, T., Izumo, T., Inomata, M., Ito, Y., Morita, K., Matsui, H., Fushimi, K., Urushiyama, H., Nagase, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24295769
Additional file 5 of Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
Awano, N., Jo, T., Izumo, T., Inomata, M., Ito, Y., Morita, K., Matsui, H., Fushimi, K., Urushiyama, H., Nagase, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26625817
Additional file 4 of Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study
Awano, N., Jo, T., Izumo, T., Inomata, M., Ito, Y., Morita, K., Matsui, H., Fushimi, K., Urushiyama, H., Nagase, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26625814
Additional file 1 of Effects of enhanced adsorption haemofiltration versus haemoadsorption in severe, refractory septic shock with high levels of endotoxemia: the ENDoX bicentric, randomized, controlled trial
Wendel‐Garcia, P. D., Eberle, B. M., Kleinert, E.-M., Hilty, M. P., Blumenthal, S., Spanaus, K., Fodor, P., & Maggiorini, M. (2023) · Figshare · doi:10.6084/m9.figshare.24819602
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · RWTH Publications (RWTH Aachen) · doi:10.5167/uzh-280465
Immunology of Sepsis
Morrell, E. D., & Mikacenic, C. R. (2025) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.11.003 · Cited by 1
Executive Summary of the 2020 Clinical Practice Guidelines for Sepsis and Septic Shock in Adults in the Philippines
Buensalido, J. A. L., Malundo, A. F. G., Aherrera, J. A. M., Magno, J. D. A., Maramara, M. K. P., Punzalan, F. E. R., Tolosa, M. T. S., Briones, G., Hernandez, A. M. R., Pantaleon, A. F., et al. (2022) · Philippine Journal of Internal Medicine · doi:10.65564/pjim.10a45be121
Endotoxin Adsorption with Polymyxin B Hemoperfusion: Mechanistic Insights and Therapeutic Implications for Septic Shock
Rizzi, F. L., Romano, L. F., & Farouk, A. (2025) · Bulletin of pioneering researches of medical and clinical science · doi:10.51847/ioqafdtd7n
Clinical applications for the endotoxin activity assay in sepsis: a scoping review
Komaru, Y., Maeda, A., Inokuchi, R., Foster, D., Kellum, J. A., & Doi, K. (2026) · Critical Care · doi:10.1186/s13054-026-05868-3
Self-citation
Chinese expert guidance on critical care hemoadsorption (2025)
Wang, C., Liu, S., Zheng, Y., Liu, Z., Liu, J., Hu, B., Ke, L., zhang, J., Jin, S., Yu, K., et al. (2025) · Journal of Translational Critical Care Medicine · doi:10.1097/jtccm-d-25-00011
Extracorporeal Blood Purification Supported by VA-ECMO in Cardiogenic Shock
Ko, R., & Yang, J. H. (2026) · Journal of Cardiovascular Intervention · doi:10.54912/jci.2025.0044
Iwatsuki Commemorative Contribution—My odyssey in critical care medicine with special reference to cytokine theory of disease and control of cytokine storm
Hirasawa, H. (2026) · Journal of the Japanese Society of Intensive Care Medicine · doi:10.3918/jsicm.33_r7
Impact of different extracorporeal blood purification strategies during continuous renal replacement therapy in septic shock patients
Kovačević, P., Spiric, N., Vučićević, K. M., Dragić, S., Momčićević, D., Zlojutro, B., Jandrić, M., Kovačević, T., & Mallat, J. (2026) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2025.12.010
Granulocyte and monocyte adsorption therapy in sepsis: a propensity score-matched analysis
Hisamune, R., Yamakawa, K., Nakamura, T., Doi, K., Takahashi, G., Moriyama, K., Ishihara, T., & Nishida, O. (2026) · Journal of Intensive Care · doi:10.1186/s40560-026-00872-9
Association between Cytokine Adsorption Therapy and Organ Dysfunction Trajectories in Septic Shock with AKI: A Retrospective Cohort Study
Kılıç, İ., Çağlayan, Y., Kiraz, H. A., Bakırdöğen, S., & Karakılıç, E. (2026) · Blood Purification · doi:10.1159/000551454
Implementing endotoxin adsorption for septic shock into clinical practice
Schupp, T., Behnes, M., & Akin, I. A. (2026) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(26)00055-x
Insuffisance rénale aiguë en réanimation : facteurs de risque d'origine iatrogène et devenir à long terme
Jamme, M. (2022) · theses.fr (ABES) · doi:10.70675/8a25e63cz6f50z4a94z8cc6z006f4a65dd09
Implication de l'axe C5a-C5aR1 dans l'orage inflammatoire des formes sévères de COVID-19 de l'adulte
Carvelli, J. (2023) · theses.fr (ABES) · doi:10.70675/be12640bzc919z4322zb146z5a584bd7ec67
การพยาบาลผปวยภาวะชอกจากการตดเชอในกระแสเลอดทไดรบการฟอกเลอดดวยตวกรองดดซบ
ทาคำสม, ภ. (2026) · The Journal of Thailand Nursing and Midwifery Council · doi:10.60099/jtnmc.v41i02.275318
oXiris in severe cardiogenic shock with endotoxemia: interpreting the negative findings of the CLEAN-ECMO trial
Honoré, P., Benkaddour, Y., Lissnyder, N. D., Khouja, R. B., & Muscato, C. (2026) · Critical Care · doi:10.1186/s13054-026-06052-3
Enrichment strategies in Precision Medicine for future clinical trials
Boussarsar, M., Ennouri, E., Saida, I. B., Meddeb, K., & Toumi, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36554-6.00024-6
Precision medicine in sepsis: lessons from the TIGRIS trial and the reawakening of targeted therapy
Iba, T., Helms, J., Okada, H., Nagakari, K., & Ferrer, R. (2026) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-026-00393-9
Impacts of hemoperfusion combined with continuous renal replacement therapy on renal function and immune function in patients with acute renal failure caused by poisoning
Fang, H., Huang, J., Fan, S., Yanlin, X., & 劉娟君 (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1827840
Revisiting hypocholesterolemia during prolonged sepsis: From targeted cholesterol repletion to unresolved adrenal and muscle dysfunction
Bruyn, L. D., Beek, F. V., Perre, S. V., Derde, S., Derese, I., Pauwels, L., den Berghe, G. V., & Langouche, L. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112848
Inflammatory Stewardship—A Perspective for Active Management of Acute Inflammation
Herrlich, L. F., Schrezenmeier, H., & Messerer, D. A. C. (2026) · The FASEB Journal · doi:10.1096/fj.202600607r
From Bench to Bedside: Implications and Interventions for Endotoxin Exposure in Lipopolysaccharide-Induced Apoptosis and Eryptosis
Guimarães, M. G., Ronco, C., Estacio, M. A., Zanella, M., & Virzì, G. M. (2026) · Blood Purification · doi:10.1159/000552431
Extrakorporale Immunmodulation in der Sepsis
Pape, T., Forster, R., Daron, T., Seeliger, B., David, S., & Stahl, K. (2026) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-026-01472-z
Dynamic changes in vasoactive-inotropic score and their prognostic value in severe sepsis and septic shock patients undergoing polymyxin B hemoperfusion: a real-world Asian ICU cohort study
Chang, W.-H., Wu, W.-J., Shen, H.-F., & Hu, T.-Y. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13907-1
Update on sepsis treatment
Chiscano‐Camón, L., Ruiz‐Rodríguez, J. C., Ruiz‐Sanmartín, A., Nicolás-Morales, P., Hernández-González, M., & Ferrer, R. (2026) · Journal of Intensive Care · doi:10.1186/s40560-026-00898-z
Early Vasoactive‐Inotropic Response Trajectories After Polymyxin B Hemoperfusion in Septic Shock: A Single‐Center Retrospective Cohort Study
Chang, W.-H., Yu, K.-P., Kuo, L., & Lee, C. (2026) · Therapeutic Apheresis and Dialysis · doi:10.1002/1744-9987.70179
Effects on mortality of different blood purification techniques in sepsis patients: an umbrella review of systematic reviews and meta-analyses
Yuan, Y., Lei, S., Duan, A., & Li, J. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2698155 · Cited by 1
TEMPORARY REMOVAL: Interpreting TIGRIS Trial: Signal Amid Methodological Uncertainty for Hemoadsorption in Sepsis
Maggiore, U., & Fiaccadori, E. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101477
Retracted
Mortality and adverse events of extracorporeal haemoadsorption therapy in cardiac surgery: a systematic review and meta-analysis of randomised controlled trials
Pittaway, H., Kelly, J. M., Price, M. J., Parekh, D., & Howells, P. A. (2026) · British Journal of Anaesthesia · doi:10.1016/j.bja.2026.06.005
Electroacupuncture as Adjunctive Therapy for Organ Dysfunction Among Chinese ICU Patients with Sepsis: Study Protocol for a Randomized Clinical Trial
Meng, Q., Yu, L.-L., Jing, X., Li, M. M., Huang, Q.-R., Xu, T. L., Bian, Y., & Li, S. (2026) · Current Medical Science · doi:10.1007/s11596-026-00225-5
Beneficial effects of PMX-DHP on vasopressor-resistant invasive meningococcal disease: a case report
Hattori, Y., Chiba, N., Ihara, S., Sato, J., Nakagawa, K., Saito, T., & Kinoshita, K. (2026) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000005384
Consensus recommendations for patient selection and clinical implementation of polymyxin B hemoadsorption in endotoxic septic shock
Yessayan, L., Legrand, M. M., Neyra, J. A., Davison, D. L., Busse, L. W., Bender, W., McMahon, B. A., Eaton, J., Morgan-Gray, T., Ramberg, C., et al. (2026) · Critical Care · doi:10.1186/s13054-026-06182-8
The Use of Extracorporeal Organ Support Therapies for Acute Kidney Injury in Cancer Patients
Atić, A., Forni, L. G., & Premužić, V. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15156024
PME loaded groove shaped fibers with tunable groove sizes for bacterial capture from blood via a size-matching effect
Bao, J., Yang, X., Liu, X., Han, Z., Chen, S., Ling, Z., Xiang, H., Chang, K., Zhao, C., & Zhao, W. (2026) · Polymer · doi:10.1016/j.polymer.2026.130633
Possible Clinical Effects of Polymyxin B-Immobilized Fiber Columns via Platelet-Derived Lipid Mediators: A Prospective Observational Study
Suzuki, S., Kazuma, S., Tatsumi, H., Masuda, Y., Koga, Y., Meguro, H., Kaino, M., & Shinohara, M. (2026) · Blood Purification · doi:10.1159/000553006
Targeting capillary leak in experimental sepsis and endotoxemia: a systematic review of therapeutic agents, methods and models in animal studies
Dumargne, H., Ly, S. H., Louzier, V., Allaouchiche, B., Hammed, A., & Dargent, A. (2026) · Critical Care · doi:10.1186/s13054-026-06160-0
Incidence and Clinical Outcomes of Circuit Clotting During Prolonged Polymyxin B Hemoperfusion in Patients With Septic Shock: A Post Hoc Analysis of a Prospective Cohort Study
Miyamoto, K., Kawazoe, Y., Morimoto, T., Yamamura, H., Miyagawa, N., Ohta, Y., Shibata, M., Shima, N., Nakashima, T., & Inoue, S. (2026) · Therapeutic Apheresis and Dialysis · doi:10.1002/1744-9987.70210
Association of oXiris Hemoadsorption with Inflammatory, Hemodynamic, Respiratory, and Organ Dysfunction Parameters in Patients with Sepsis and Septic Shock in the Intensive Care Unit: A Retrospective Comparative Cohort Study
Orhan, S., Ay, M., Ay, M., & Gulsoy, K. (2026) · Life · doi:10.3390/life16081367
Timing of hemoadsorption in sepsis: redefining early through mediator-guided therapy
Kusirisin, P., Kellum, J. A., & Srisawat, N. (2026) · Journal of Intensive Care · doi:10.1186/s40560-026-00932-0
Progress in the Diagnosis and Treatment of Urosepsis: A Review
罗, 楠. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1683012
Precision therapy for endotoxic septic shock: a step toward personalized treatment from EUPHAS to TIGRIS
Lee, S. H. (2026) · Acute and Critical Care · doi:10.4266/acc.007228
Blood Purification in Cardiac Surgery and Transplantation
Bernardi, M. H. (2026) · Springer eBooks · doi:10.1007/978-3-032-27033-7_9
Artificial Intelligence and Personalized Blood Purification
Cutuli, S. L. (2026) · Springer eBooks · doi:10.1007/978-3-032-27033-7_3
Emerging Biotechnologies in Blood Purification
Vernon-Elliot, J., Schleef, M., & See, E. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-27033-7_19
Personalisierte Sepsistherapie und moderne Studiendesigns
David, S., Erlebach, R., Buhlmann, A., & Müller, M. M. (2026) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-026-01495-6
Sepsis and Septic Shock
Reddi, B. A. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-31459-8_2
The effects of hemoadsorption in patients with sepsis-associated persistent severe AKI who require CRRT: A prospective, randomized controlled pilot study
Shi, K., Jiang, W., Song, L., Wang, Y.-C., Li, X.-H., Wang, J., Shi, Y., Yang, Z.-X., Cai, X.-Z., Han, W., et al. (2026) · Annals of Intensive Care · doi:10.1016/j.aicoj.2026.100167
Strain-specific magnetic nanoantidote with lipopolysaccharide recognition for systemic immune reprogramming in drug-resistant sepsis
Dong, W., Pan, X., Xu, Z., Li, Q., Yao, M., Zhang, C., Chen, P., & Feng, S. (2026) · Nano Today · doi:10.1016/j.nantod.2026.103196
Management of abdominal sepsis: Principles, pitfalls, and perspectives
Sartelli, M. (2026) · Intensive Care Science · doi:10.1016/j.iics.2026.08.004
Kidney replacement therapy in acute kidney injury: Evidence to guide clinical decision-making
Costa-Alves, P. R., Custódio, F. B., Franco, A. C., Junior, R. F. A., Balbi, A. L., Zamoner, W., & Ponce, D. (2026) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2026.08.006
Nanomaterial-mediated inflammatory cytokine clearance and immune repair: A new frontier in managing critical inflammation
Liu, S., Xiong, H., Lu, C., & Yang, F. (2026) · Progress in Natural Science Materials International · doi:10.1016/j.pnsc.2026.09.007
From early recognition to precision medicine: advances in the diagnosis and management of adult sepsis and septic shock—a narrative review
Koca, H., & Ayvat, P. U. (2026) · Infection · doi:10.1007/s15010-026-03019-y
Pathogen-associated heterogeneity in pulmonary sepsis: from inflammatory phenotypes and transcriptomic endotypes to precision medicine
Wang, C., Xi, C., Zhang, Y., Ma, R.-F., Shi, M.-M., Gao, Y., Liu, L.-P., Ning, C.-Y., & Chen, A.-B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1973456
Técnicas extracorpóreas de purificación sanguínea en los pacientes con sepsis: una revisión narrativa
Muñoz, F., Arias, J. M., Ríos, J. F. N., & Walteros, O. H. (2026) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2026.100669
Extracorporeal detoxification methods in the comprehensive therapy of severe cholangiogenic sepsis: a prospective observational study
Sadullayev, M. M., Рахманов, К. Э., & Davlatov, S. (2026) · EMERGENCY MEDICINE · doi:10.22141/2224-0586.22.6.2026.2053

Authors: Dellinger, R. P., Bagshaw, S. M., Antonelli, M., Foster, D. M., Klein, D. J., Marshall, J. C., Palevsky, P. M., Weisberg, L. S., Schorr, C. A., Trzeciak, S., Walker, P. M., & for the EUPHRATES Trial Investigators
Affiliations: Cooper University Hospital (US)
University of Alberta (CA)
Università Cattolica del Sacro Cuore (IT)
Spectral Medical Inc, Toronto, Canada
St. Michael's Hospital (CA)
University of Pittsburgh (US)
Corresponding author: Dellinger, R. Phillip
ORCID: Bagshaw, Sean M.
Antonelli, Massimo
Klein, David J.
Marshall, John C.
Palevsky, Paul M.
Weisberg, Lawrence S.
Schorr, Christa A.
Trzeciak, Stephen
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2018-10-09
Volume: 320
Issue: 14
Pages: 1455
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2018.14618
PMC: PMC6233793
OpenAlex: W2897735762
Cited by: 502
References: 25
Citations by year: 2026: 73 · 2025: 71 · 2024: 71 · 2023: 70 · 2022: 52 · 2021: 54 · 2020: 63 · 2019: 40 · 2018: 5
FWCI: 31.62
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: JAMA (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Figshare (submittedVersion)
Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
Funders: University of Nebraska Medical Center
Memorial Sloan-Kettering Cancer Center
Cleveland Clinic
University of Pittsburgh
East Carolina University
Thomas Jefferson University
Temple University
University of Alberta
Medical Center, University of Pittsburgh
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords: polymyxin B hemoperfusion, septic shock, endotoxin activity, endotoxemia, 28-day mortality, multiple organ failure, sepsis, critically ill patients, endotoxin activity assay, survival outcomes, sepsis treatment, APACHE II score, multiple organ dysfunction score, sepsis mortality
MeSH terms: Adult, Aged, Anti-Bacterial Agents, Endotoxins, Female, Humans, Male, Middle Aged, Polymyxin B, Shock, Septic, Survival Analysis, Hospital Mortality, APACHE

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks